Ajinomoto to acquire Forge Biologics for $620 million
19.27BUSD
Type
Common Stock
Exchange
OTCGREY
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Consumer Defensive
Industry
Packaged Foods
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
34.15
PEG Ratio
2.71
Book Value
1,632.34
Dividend Share
74
Dividend Yield
1.35%
Earnings Share
1.12
Wall Street Target Price
131.19
EPS Estimate Current Year
0
EPS Estimate Next Year
0
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
1,465,217,974,272
Gross Profit TTM
425,898,000,000
EBITDA
227,855,007,744
Profit Margin
5.72%
Return On Assets TTM
5.26%
Return On Equity TTM
11.40%
Revenue Per Share TTM
2837.269
Qtly Revenue Growth YOY
7.70%
Diluted Eps TTM
1.12
Qtly Earnings Growth YOY
-9.20%
Trailing PE
34.15
Forward PE
26
Price Sales TTM
0.0132
Price Book MRQ
3.4454
Enterprise Value Revenue
2
Enterprise Value EBITDA
12
81.45
0.28%23.82
0.00%65.46
-2.18%58.96
-0.61%71.20
-0.42%81.21
-0.20%40.15
-0.12%13.09
-0.08%81.43
-0.07%28.78
-0.03%Ajinomoto to acquire Forge Biologics for $620 million
Ajinomoto to acquire Forge Biologics for $620 million in all-cash deal